CP Pharma SPRL
The score of CP Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -33 % Total assets -42 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
CP Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 19,546 € | ||||
| Equity | 351,602 € | ||||
| Cash | 170,278 € | ||||
| EBITDA | 25,621 € | ||||
| Total assets | 375,380 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 May 2026
- Year ended 31 Dec 2024filed on 09 May 2025
- Year ended 31 Dec 2023filed on 18 Apr 2024
- Year ended 31 Dec 2022filed on 03 Aug 2023
- Year ended 31 Dec 2021filed on 15 Jul 2022
CP Pharma's financial analysis
- Solvency93.7%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of CP Pharma
CP Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0865.720.644
- VAT number
- BE0865720644
- Peppol
- Not found on Peppol as of 09 Nov 2026 · Check
- Legal form
- SPRL
- Incorporated
- 19 May 2004
- Registered office
- 4620 Fléron
- Latest accounts
- 2025 · filed on 19 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
CP Pharma (SPRL) has been based in Fléron since 2004, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 19,546 € and equity of 351,602 €; its revenue is not published. Its solvency stands at 93.7%, above the median of its sector (41.5%).
Companies similar to CP Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Apotheek Hilde Lippens Retail sale of pharmaceutical products Knokke-Heist · balance sheet 378,020 €
- Van de Keere Retail sale of pharmaceutical products Zottegem · balance sheet 366,717 €
- Natexis Retail sale of pharmaceutical products Auderghem · balance sheet 404,337 €
- Dewez Invest Retail sale of pharmaceutical products Visé · balance sheet 419,029 €
- Vereenooghe SEW Retail sale of pharmaceutical products Ledegem · balance sheet 426,561 €
- Farmacerèye Retail sale of pharmaceutical products Liège · balance sheet 326,499 €
- Yapharm Retail sale of pharmaceutical products Uccle · balance sheet 436,227 €
Frequently asked questions about CP Pharma
What is the revenue of CP Pharma?
CP Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of CP Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0865720644 for CP Pharma, if the company is VAT-registered. Its company number (CBE) is 0865.720.644.
Where is the registered office of CP Pharma?
According to the CBE register, the registered office of CP Pharma is in 4620 Fléron.
What is the equity of CP Pharma?
At the close of the 2025 financial year, the equity of CP Pharma amounts to 351,602 €, a solvency of 93.7% of total assets.
Who manages CP Pharma?
The register lists 1 active mandates at CP Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of CP Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →